Question 1

Am I eligible for this trial based on my specific diagnosis?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the ctDNA in HER2+ EBC Neoadjuvant Treatment clinical trial (NCT07335081). Contact the study team or your healthcare provider for specific answers.

Question 2

How do the treatments being tested compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the ctDNA in HER2+ EBC Neoadjuvant Treatment clinical trial (NCT07335081). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of the treatments in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the ctDNA in HER2+ EBC Neoadjuvant Treatment clinical trial (NCT07335081). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatment and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the ctDNA in HER2+ EBC Neoadjuvant Treatment clinical trial (NCT07335081). Contact the study team or your healthcare provider for specific answers.

Question 5

What does the trial involve in terms of tests and procedures?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the ctDNA in HER2+ EBC Neoadjuvant Treatment clinical trial (NCT07335081). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the ctDNA in HER2+ EBC Neoadjuvant Treatment clinical trial (NCT07335081). Contact the study team or your healthcare provider for specific answers.

What this study is about